Seer Inc Cash Flow Conversion Efficiency
Seer Inc cash flow conversion efficiency. Based on the latest financial reports, Seer Inc (SEER) has a cash flow conversion efficiency ratio of -0.042x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-9.57 Million) by net assets ($225.68 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Seer Inc (2018–2025)
Cash flow conversion efficiency of Seer Inc from 2018 to 2025. This chart illustrates how Seer Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Seer Inc stock quote for real-time trading data and today's change.
Seer Inc Cash Flow Conversion Ratio Explained
Seer Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Seer Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Seer Inc ranked by their cash flow conversion efficiency. Also see Seer Inc market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Buligo Capital Ltd
TA:BLGO
|
-0.137x |
|
Sagittarius Life Science
TWO:3205
|
-0.020x |
|
Pacific Construction Co Ltd
TW:2506
|
0.013x |
|
Investeringsselskabet Luxor A/S
CO:LUXOR-B
|
0.030x |
|
Lang Inc
TW:6165
|
0.065x |
|
SRM CONTRACTORS ORD (BSE)
NSE:SRM
|
-0.025x |
|
Antony Waste Handling Cell Limited
NSE:AWHCL
|
0.036x |
|
Sunrise Realty Trust, Inc.
NASDAQ:SUNS
|
0.002x |
Annual Cash Flow Conversion Efficiency for Seer Inc (2018–2025)
The table below shows the annual cash flow conversion efficiency of Seer Inc from 2018 to 2025. Review SEER financial flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $259.31 Million | $-44.45 Million | -0.171x | -21.77% |
| 2024-12-31 | $327.57 Million | $-46.11 Million | -0.141x | +5.41% |
| 2023-12-31 | $396.90 Million | $-59.06 Million | -0.149x | -9.44% |
| 2022-12-31 | $446.99 Million | $-60.78 Million | -0.136x | -47.55% |
| 2021-12-31 | $502.92 Million | $-46.35 Million | -0.092x | -90.97% |
| 2020-12-31 | $431.61 Million | $-20.83 Million | -0.048x | +67.63% |
| 2019-12-31 | $87.68 Million | $-13.07 Million | -0.149x | +3.91% |
| 2018-12-31 | $29.98 Million | $-4.65 Million | -0.155x | -- |
About Seer Inc
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis … Read more